MobbleOpen in Mobble ⇢
Business · Stock markets · published 2026-10-11 · via Tikr

BMO Trims Albemarle Target but Sticks With Outperform

Image via Tikr
Image via Tikr

Albemarle closed at $102.75 on Oct. 7, down 52% from its April high. BMO cut its target to $175 from $200 but kept an Outperform rating, implying 70% upside. Management lowered Q3 Energy Storage guidance on weaker volumes and pricing, and 2027 consensus EPS has declined.

Expanded Detail

Albemarle ended Oct. 7 at $102.75, roughly half its April 16 closing high of $215.62. BMO lowered its target to $175 from $200 on Oct. 6 while retaining an Outperform rating, still implying about 70% upside. UBS and Argus also reduced targets that week but kept Buy ratings.

Management expects third-quarter Energy Storage sales and adjusted EBITDA to fall sequentially on softer volumes and pricing. Over 90 days, the 2027 consensus EPS estimate slipped to $11.00 from $12.98. After a June fire at Talison's CGP3 plant, the company expects 225 to 235 kilotons of 2026 Energy Storage sales.

Context

The BMO call and lithium outlook could affect investors holding Albemarle shares, employees and communities tied to lithium mining, and battery/EV supply chains. If prices stay weak, project spending or hiring may slow; if they recover, costs for batteries and EVs may face pressure. Analysts' target changes may influence sentiment but not directly determine outcomes.

Expanded detail and Context are AI-generated analysis; the linked article remains the authoritative source.
Read the full article at Tikr →
Related stories
Needham Reaffirms $40 Target for Unusual Machines After Pullback · Stock markets
Jefferies Keeps Buy on PROG Holdings Despite 30% Slide · Stock markets
Snowflake Shares Climb as CFO Keeps CoCo Forecast Conservative · Stock markets
Cipher Digital’s Sharp Decline Puts Focus on Upcoming Lease · Stock markets
This summary is Al-enhanced to contain extended analysis and broader social context. The original is {NAME); the linked article is the authoritative source. Original headline: “Albemarle Has Lost 52% Since April: BMO Sees 70% Upside.” Browse more stories.